Creades AB Series A
Creades AB is a private equity and venture capital investment firm specializing in early, mid & late venture, emerging growth, middle market, growth capital and buyout investments. The firm typically invests in small and medium-sized public and private companies. It focuses on Swedish companies. The firm seeks to invest between SEK50 million ($4.78 million) and SEK500 million ($47.91 million). Th… Read more
Creades AB Series A (0QI9) - Net Assets
Latest net assets as of December 2025: Skr11.15 Billion SEK
Based on the latest financial reports, Creades AB Series A (0QI9) has net assets worth Skr11.15 Billion SEK as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr11.25 Billion) and total liabilities (Skr95.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr11.15 Billion |
| % of Total Assets | 99.16% |
| Annual Growth Rate | 9.13% |
| 5-Year Change | -13.83% |
| 10-Year Change | 236.1% |
| Growth Volatility | 27.49 |
Creades AB Series A - Net Assets Trend (2012–2025)
This chart illustrates how Creades AB Series A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Creades AB Series A (2012–2025)
The table below shows the annual net assets of Creades AB Series A from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr11.15 Billion | +9.80% |
| 2024-12-31 | Skr10.16 Billion | +10.72% |
| 2023-12-31 | Skr9.18 Billion | +4.17% |
| 2022-12-31 | Skr8.81 Billion | -31.96% |
| 2021-12-31 | Skr12.95 Billion | +62.81% |
| 2020-12-31 | Skr7.95 Billion | +72.47% |
| 2019-12-31 | Skr4.61 Billion | +24.63% |
| 2018-12-31 | Skr3.70 Billion | +8.83% |
| 2017-12-31 | Skr3.40 Billion | +2.41% |
| 2016-12-31 | Skr3.32 Billion | +5.33% |
| 2015-12-31 | Skr3.15 Billion | +11.26% |
| 2014-12-31 | Skr2.83 Billion | +1.65% |
| 2013-12-31 | Skr2.79 Billion | -22.24% |
| 2012-12-31 | Skr3.58 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Creades AB Series A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | Skr11.15 Billion | 100.00% |
| Total Equity | Skr11.15 Billion | 100.00% |
Creades AB Series A Competitors by Market Cap
The table below lists competitors of Creades AB Series A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EROAD Limited
PINK:ERDLF
|
$81.74 Million |
|
Magnora ASA
OL:MGN
|
$81.76 Million |
|
Enviro Infra Engineers Ltd
NSE:EIEL
|
$81.78 Million |
|
Gujarat Alkalies and Chemicals Limited
NSE:GUJALKALI
|
$81.78 Million |
|
Singer Thailand Public Company Limited
BK:SINGER-R
|
$81.71 Million |
|
Steel Strips Wheels Limited
NSE:SSWL
|
$81.71 Million |
|
Anglo Asian Mining PLC
PINK:AGXKF
|
$81.69 Million |
|
Martin Midstream Partners LP
NASDAQ:MMLP
|
$81.68 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Creades AB Series A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,159,000,000 to 11,155,000,000, a change of 996,000,000 (9.8%).
- Net income of 1,213,000,000 contributed positively to equity growth.
- Dividend payments of 217,000,000 reduced retained earnings.
- Other comprehensive income increased equity by 1,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr1.21 Billion | +10.87% |
| Dividends Paid | Skr217.00 Million | -1.95% |
| Other Comprehensive Income | Skr1.00 Million | +0.01% |
| Other Changes | Skr-1.00 Million | -0.01% |
| Total Change | Skr- | 9.80% |
Book Value vs Market Value Analysis
This analysis compares Creades AB Series A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.83x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 5.18x to 0.83x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | Skr13.10 | Skr67.85 | x |
| 2012-12-31 | Skr12.02 | Skr67.85 | x |
| 2013-12-31 | Skr15.05 | Skr67.85 | x |
| 2014-12-31 | Skr19.50 | Skr67.85 | x |
| 2015-12-31 | Skr23.02 | Skr67.85 | x |
| 2016-12-31 | Skr25.58 | Skr67.85 | x |
| 2017-12-31 | Skr26.62 | Skr67.85 | x |
| 2018-12-31 | Skr29.67 | Skr67.85 | x |
| 2019-12-31 | Skr36.98 | Skr67.85 | x |
| 2020-12-31 | Skr63.79 | Skr67.85 | x |
| 2021-12-31 | Skr98.71 | Skr67.85 | x |
| 2022-12-31 | Skr64.87 | Skr67.85 | x |
| 2023-12-31 | Skr67.58 | Skr67.85 | x |
| 2024-12-31 | Skr74.83 | Skr67.85 | x |
| 2025-12-31 | Skr82.17 | Skr67.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Creades AB Series A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.87%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 479.45%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 1.01x
- Recent ROE (10.87%) is below the historical average (12.53%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -4.00% | -290.70% | 0.01x | 1.17x | Skr-437.20 Million |
| 2013 | 30.11% | 86.60% | 0.30x | 1.16x | Skr543.70 Million |
| 2014 | 14.89% | 80.00% | 0.17x | 1.11x | Skr138.00 Million |
| 2015 | 17.56% | 49.06% | 0.33x | 1.07x | Skr236.00 Million |
| 2016 | 9.45% | 25.35% | 0.34x | 1.08x | Skr-17.80 Million |
| 2017 | 7.35% | 19.26% | 0.35x | 1.08x | Skr-87.80 Million |
| 2018 | 14.33% | 41.31% | 0.34x | 1.01x | Skr160.10 Million |
| 2019 | 23.56% | 96.02% | 0.24x | 1.01x | Skr625.00 Million |
| 2020 | 45.87% | 90.86% | 0.48x | 1.05x | Skr2.85 Billion |
| 2021 | 32.39% | 93.82% | 0.33x | 1.04x | Skr2.90 Billion |
| 2022 | -44.83% | 0.00% | -0.46x | 1.03x | Skr-4.83 Billion |
| 2023 | 6.08% | 103.72% | 0.06x | 1.02x | Skr-359.50 Million |
| 2024 | 11.83% | 94.20% | 0.12x | 1.02x | Skr186.10 Million |
| 2025 | 10.87% | 479.45% | 0.02x | 1.01x | Skr97.50 Million |
Industry Comparison
This section compares Creades AB Series A's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Creades AB Series A (0QI9) | Skr11.15 Billion | -4.00% | 0.01x | $81.71 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |